Home > Boards > US OTC > Biotechs >

Delcath Systems Inc. (DCTHD)

Add DCTHD Price Alert      Hide Sticky   Hide Intro
Moderator: CanadaGreece, TheGreatGuy
Search This Board: 
Last Post: 10/23/2019 8:54:45 PM - Followers: 521 - Board type: Free - Posts Today: 6

Web Site: Delcath Systems, Inc.
Stock and Financial Info: OTC Marketplace
About Delcath Systems (OTCQB:DCTH)
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Their proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In the United States, the Melphalan/HDS system is considered a combination drug and device product, and is regulated as a drug by the United States Food and Drug Administration (FDA). The Melphalan/HDS system has not been approved for sale in the United States. In Europe, their proprietary system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In April 2012, they obtained authorization to affix a CE Mark for the Generation Two CHEMOSAT system. The right to affix the CE mark allows the Company to market and sell the CHEMOSAT system in Europe. The Company has commenced a global phase 2 clinical trial in Europe to investigate Melphalan/HDS system for primary liver cancer and is initiating plans to evaluate intrahepatic cholangiocarcinoma.
Delcath Systems was formed in 1988 as a Pharmaceutical and Medical Device company focused on oncology. The company is registered in Delaware with offices in New York, New York and Manufacturing, Distribution, Research and Development facilities located in Queensbury, New York. The company currently has 10 patents in their US Intellectual Property portfolio according to the US Patent Office.
Subsidiaries of Delcath Systems include Delcath Holdings Limited (Ireland), Delcath Systems Limited (Ireland), Delcath Systems B.V. (Netherlands), Delcath Systems Gmbh (Germany) and Delcath Systems UK (United Kingdom).
Delcath Systems Securities
Delcath Systems securities originally came on the market on June 16, 2000 with an IPO offering of 1.2m shares priced at $6.00 per share. Securities were listed on both the NASDAQ and Boston Stock Exchange. The stock moved from the NASDAQ to the OTCQB on September 15, 2017 after the company Voluntarily Delisted it from NASDAQ and requested an Accelerated listing in the OTC marketplace.

Stock Split History
The stock has been (reverse) split a total of 4 times. Twice while on the NASDAQ and twice since moving to the OTCQB.
The 1st split came on April 9, 2014 at a ratio of 1:16
The 2nd split came on July 21, 2016 at a ratio of 1:16
The 3rd split came on November 6, 2017 at a ratio of 1:350
The 4th split came on May 2, 2018 at a ratio of 1:500

Delcath Share Information
Common Shares Authorized: 1,000,000,000
Preferred Shares Authorized: 
Common Shares Outstanding*: 17,464,807 (a/o 5/01/2019)
Preferred Shares Outstanding**: (a/o 4/02/2019) 

Fully Diluted Common Shares as of November 5, 2018 ***

* From OTC Markets on 05/01/2019 / ** From SEC Filing 04/02/1019 / *** From SEC Filing on 11/07/2018
Delcath Systems Clinical Trials
Declcath Systems currently has two clinical trials underway. The first is the FOCUS Trial and the second the ALIGN Trial.
The FOCUS Trial is designed to evaluate patients who have melanoma that has spread from the eye to the liver. All patients in the study will be treated with Melphalan/HDS for up to 6 treatments. This study will evaluate the safety and effects of the treatment on how long patients live and how long it takes for the cancer to advance or respond to the treatment. The FOCUS Trial has an estimated completion date of April 2020. For more info click here  
The ALIGN Trial will evaluate two groups of patients who have intrahepatic cholangiocarcinoma. Each group will receive induction treatment with Cisplatin and Gemcitabine per SOC for 4 treatment cycles. Following induction treatment patients will be randomize (1:1), to 2 arms of treatment. One group (50%) will rreceive high dose chemotherapy delivered specifically to the liver, while the other group (50%) will continue treatment with Cisplatin and Gemcitabine. Patient in each group will get repeating cycles of treatment until the cancer advances. All patients will be followed until death. This study will compare the overall survival (OS) in patients with intrahepatic cholangiocarcinoma. The ALIGN Trial has an estimated completion date of January 2023. For more info click here
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DCTH News: Current Report Filing (8-k) 04:42 PM
DCTH News: Current Report Filing (8-k) 10/01/2019 04:03:46 PM
DCTH News: Securities Registration Statement (s-1/a) 09/25/2019 05:28:34 PM
DCTH News: Current Report Filing (8-k) 09/19/2019 05:15:53 PM
DCTH News: Small Company Offering and Sale of Securities Without Registration (d) 08/27/2019 02:54:57 PM
#49442   I wonder what would happen if FINRA takes Muenster Madness 10/23/19 08:54:45 PM
#49441   It will get bought off of every tap Filterthenoise 10/23/19 05:05:18 PM
#49440   looks like new investors are getting itchy to Bond 10/23/19 04:58:56 PM
#49439   Countless stocks go below financing price more often CanadaGreece 10/23/19 02:43:15 PM
#49438   Nah. It won’t. .06 at most. Muenster Madness 10/23/19 01:56:43 PM
#49437   is it going to .05 ? TheGreatGuy 10/23/19 01:18:05 PM
#49436   Shits so tight they all share one laptop! Tossil 10/22/19 04:07:55 PM
#49435   I sent an email saying they owed investors Muenster Madness 10/22/19 03:43:34 PM
#49434   you should also enjoy their shiny new website Bond 10/22/19 03:31:23 PM
#49433   No problem...just wanted to make you were aware Lwe6638 10/22/19 02:13:38 PM
#49432   Lwe6638, do not shoot the messenger. FINRA reported it; flaflyersfan 10/22/19 01:02:05 PM
#49431   Million dollar question CanadaGreece 10/22/19 12:51:47 PM
#49430   Is it the last buying opportunity or losing opportunity? TheGreatGuy 10/22/19 12:23:02 PM
#49429   I'm in the limb with you. Filterthenoise 10/22/19 11:38:51 AM
#49428   https://seekingalpha.com/news/3507837-delcath-postpones-reverse-split#email_link Lwe6638 10/22/19 11:23:03 AM
#49427   It was supposed to but read the news CanadaGreece 10/22/19 11:04:15 AM
#49426   Sorry...but it did not occur per the PR Lwe6638 10/22/19 11:02:52 AM
#49425   Lwe6638, the Reverse Split occurred after market close flaflyersfan 10/22/19 10:55:02 AM
#49424   You are wrong. They have a RS approved Lwe6638 10/22/19 10:33:50 AM
#49423   Going out on a limb and suggesting a CanadaGreece 10/22/19 10:27:01 AM
#49422   Lwe6638, the DCTHD Reverse Split already happened. EOM flaflyersfan 10/22/19 10:26:28 AM
#49421   FINRA doesnt decide whether the RS can happen Lwe6638 10/22/19 10:08:11 AM
#49420   It never seemed right to do. Either way Filterthenoise 10/22/19 10:02:52 AM
#49419   Crooks OR readers of Ecclesiastes, there is a SAMNOTSAMUEL 10/22/19 09:08:46 AM
#49418   LOL - Yeah - Just saw this: ddaurelio 10/22/19 08:24:28 AM
#49417   This is a new one. Reverse split CanadaGreece 10/22/19 08:19:14 AM
#49416   Likely back to $6 (0.06) for a bit. Filterthenoise 10/21/19 06:35:14 PM
#49415   DCTH one for 100 reverse split: Renee 10/21/19 06:03:09 PM
#49414   My hope. Is that those that invested millions Muenster Madness 10/21/19 03:33:13 PM
#49413   some crooks will come and will say that TheGreatGuy 10/21/19 03:25:59 PM
#49412   It sucks to really want a company to Muenster Madness 10/21/19 03:19:42 PM
#49411   1/100 reverse Split tonight for DCTH smitter 10/21/19 11:45:37 AM
#49410   cheers to no position, that's way much better Bond 10/18/19 05:38:02 PM
#49409   I don't see how these guys can make SAMNOTSAMUEL 10/18/19 05:23:09 PM
#49408   well we shall see, the movement has already started. Bond 10/18/19 05:13:48 PM
#49407   I am far from saying you have nailed SAMNOTSAMUEL 10/18/19 05:06:13 PM
#49406   It will be right at $38. No Muenster Madness 10/18/19 04:56:30 PM
#49405   I did the same thing right up to Human_Tripod 10/18/19 04:21:00 PM
#49404   Well I’ve continued to average in. Down to Muenster Madness 10/18/19 04:01:46 PM
#49403   here we go, it's that time of year Bond 10/18/19 12:19:37 PM
#49402   Reverse split 1 for 100 PStockPickz 10/18/19 09:15:19 AM
#49401   And this is the most active delcath board SAMNOTSAMUEL 10/16/19 07:39:44 AM
#49400   I haven’t seen this board so quiet in Muenster Madness 10/16/19 06:17:09 AM
#49399   Let’s hope they don’t drop it to that Muenster Madness 10/11/19 11:48:33 PM
#49398   5 cent would be perfect upcoming price. 5*100=500=5$ TheGreatGuy 10/11/19 04:03:31 PM
#49397   One 320 thousand share block at .08. Yikes lol CanadaGreece 10/11/19 01:13:50 PM
#49396   Really quiet. Wonder if we will get Muenster Madness 10/11/19 11:13:45 AM
#49395   I live in Austin but I would only SAMNOTSAMUEL 10/08/19 11:58:03 AM
#49394   Delcath Systems to Present at the MicroCap Rodeo Muenster Madness 10/08/19 11:24:13 AM
#49393   I like to call it strategically losing :) Muenster Madness 10/02/19 12:06:47 PM